S&P 500   5,105.65 (+0.18%)
DOW   38,931.77 (-0.17%)
QQQ   440.36 (+0.31%)
AAPL   179.31 (-0.80%)
MSFT   412.09 (-0.37%)
META   498.54 (+1.72%)
GOOGL   138.00 (-0.33%)
AMZN   176.73 (-0.02%)
TSLA   200.03 (-0.92%)
NVDA   803.15 (+1.52%)
NIO   5.71 (-0.70%)
AMD   197.91 (+2.79%)
BABA   74.67 (+0.86%)
T   16.98 (+0.30%)
F   12.52 (+0.64%)
MU   94.07 (+3.82%)
CGC   3.22 (-2.13%)
GE   157.96 (+0.68%)
DIS   111.52 (-0.05%)
AMC   4.41 (+2.08%)
PFE   26.70 (+0.53%)
PYPL   60.57 (+0.38%)
XOM   106.18 (+1.59%)
S&P 500   5,105.65 (+0.18%)
DOW   38,931.77 (-0.17%)
QQQ   440.36 (+0.31%)
AAPL   179.31 (-0.80%)
MSFT   412.09 (-0.37%)
META   498.54 (+1.72%)
GOOGL   138.00 (-0.33%)
AMZN   176.73 (-0.02%)
TSLA   200.03 (-0.92%)
NVDA   803.15 (+1.52%)
NIO   5.71 (-0.70%)
AMD   197.91 (+2.79%)
BABA   74.67 (+0.86%)
T   16.98 (+0.30%)
F   12.52 (+0.64%)
MU   94.07 (+3.82%)
CGC   3.22 (-2.13%)
GE   157.96 (+0.68%)
DIS   111.52 (-0.05%)
AMC   4.41 (+2.08%)
PFE   26.70 (+0.53%)
PYPL   60.57 (+0.38%)
XOM   106.18 (+1.59%)
S&P 500   5,105.65 (+0.18%)
DOW   38,931.77 (-0.17%)
QQQ   440.36 (+0.31%)
AAPL   179.31 (-0.80%)
MSFT   412.09 (-0.37%)
META   498.54 (+1.72%)
GOOGL   138.00 (-0.33%)
AMZN   176.73 (-0.02%)
TSLA   200.03 (-0.92%)
NVDA   803.15 (+1.52%)
NIO   5.71 (-0.70%)
AMD   197.91 (+2.79%)
BABA   74.67 (+0.86%)
T   16.98 (+0.30%)
F   12.52 (+0.64%)
MU   94.07 (+3.82%)
CGC   3.22 (-2.13%)
GE   157.96 (+0.68%)
DIS   111.52 (-0.05%)
AMC   4.41 (+2.08%)
PFE   26.70 (+0.53%)
PYPL   60.57 (+0.38%)
XOM   106.18 (+1.59%)
S&P 500   5,105.65 (+0.18%)
DOW   38,931.77 (-0.17%)
QQQ   440.36 (+0.31%)
AAPL   179.31 (-0.80%)
MSFT   412.09 (-0.37%)
META   498.54 (+1.72%)
GOOGL   138.00 (-0.33%)
AMZN   176.73 (-0.02%)
TSLA   200.03 (-0.92%)
NVDA   803.15 (+1.52%)
NIO   5.71 (-0.70%)
AMD   197.91 (+2.79%)
BABA   74.67 (+0.86%)
T   16.98 (+0.30%)
F   12.52 (+0.64%)
MU   94.07 (+3.82%)
CGC   3.22 (-2.13%)
GE   157.96 (+0.68%)
DIS   111.52 (-0.05%)
AMC   4.41 (+2.08%)
PFE   26.70 (+0.53%)
PYPL   60.57 (+0.38%)
XOM   106.18 (+1.59%)
NYSE:UPC

Universe Pharmaceuticals (UPC) Stock Price, News & Analysis

$1.83
-0.05 (-2.66%)
(As of 09:48 AM ET)
Today's Range
$1.82
$1.88
50-Day Range
$1.22
$2.82
52-Week Range
$0.75
$5.88
Volume
1,959 shs
Average Volume
119,595 shs
Market Capitalization
$6.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

UPC stock logo

About Universe Pharmaceuticals Stock (NYSE:UPC)

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is based in Ji'An, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited.

UPC Stock Price History

UPC Stock News Headlines

Americans Now Favor Gold Over Stocks as an Investment Vehicle
Americans now consider gold a better long-term investment than stocks for the first time since 2013. But physical gold requires storage and insurance, and gold mining stocks come with significant risks. Fortunately, investors have found a little-known way to benefit from gold that avoids many of these challenges.
Universe Pharmaceuticals (NYSE:UPC) Trading Up 43%
Universe Pharmaceuticals Inc (UPC)
Americans Now Favor Gold Over Stocks as an Investment Vehicle
Americans now consider gold a better long-term investment than stocks for the first time since 2013. But physical gold requires storage and insurance, and gold mining stocks come with significant risks. Fortunately, investors have found a little-known way to benefit from gold that avoids many of these challenges.
Universe Pharmaceuticals Inc UPC
Marvel Cinematic Universe
Universe of Art
UPC Universe Pharmaceuticals INC
UPC declares insolvency, appointed to receivership
See More Headlines
Receive UPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Universe Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/01/2024
Next Earnings (Estimated)
4/30/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Fax
N/A
Employees
225
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$32.31 million
Book Value
$10.91 per share

Miscellaneous

Free Float
1,545,000
Market Cap
$6.82 million
Optionable
Not Optionable
Beta
1.81
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for March 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Gang Lai (Age 56)
    CEO & Chairman
  • Ms. Lin Yang (Age 48)
    CFO & Director
  • Mr. Baochang Liu (Age 44)
    Chief Operating Officer














UPC Stock Analysis - Frequently Asked Questions

How have UPC shares performed in 2024?

Universe Pharmaceuticals' stock was trading at $2.01 at the start of the year. Since then, UPC stock has decreased by 9.0% and is now trading at $1.83.
View the best growth stocks for 2024 here
.

When is Universe Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 30th 2024.
View our UPC earnings forecast
.

When did Universe Pharmaceuticals' stock split?

Shares of Universe Pharmaceuticals reverse split on the morning of Friday, July 28th 2023. The 1-6 reverse split was announced on Friday, July 28th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, July 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

When did Universe Pharmaceuticals IPO?

(UPC) raised $30 million in an initial public offering on Tuesday, March 23rd 2021. The company issued 5,000,000 shares at $5.00-$7.00 per share. Univest Securities, LLC served as the underwriter for the IPO.

How do I buy shares of Universe Pharmaceuticals?

Shares of UPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:UPC) was last updated on 3/1/2024 by MarketBeat.com Staff